Company profile
ReST THERAPEUTICS
Helping Patients Reclaim Their Lives From Stress and Trauma
- Industry
- Biotechnology
- Employees
- 10
- Headquarters
- New Haven, Connecticut
- Founded
- 2020
- LinkedIn followers
- 1,852
- Office locations
- 3
ReST THERAPEUTICS company summary
ReST THERAPEUTICS is a company in the Biotechnology industry, headquartered in New Haven, Connecticut, founded in 2020. On LinkedIn the company has around 10 employees and 1,852 followers. The company lists 3 office locations. Its listed specialties include Pharmaceutical development, PTSD, Neuropsychiatry, Neuroinflammation, Neurodegeneration.
What technology does ReST THERAPEUTICS use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ReST THERAPEUTICS
ReST Therapeutics is patient-centric, precision neuropsychiatric biotech developing transformative therapies for significant unmet medical needs. Founded in Paris, France in 2020 with an additional office in New Haven, Connecticut, (USA), our novel platform is engineered to address the pathophysiology of diseases rather than just the resulting symptoms. Our lead program, RST-101, will disrupt the existing PTSD treatment paradigm, focusing on the early treatment in the aftermath of a traumatic event and a patient-centric clinical strategy. RST-101 selectively targets the specific NMDA receptors sub-types, critical to memory consolidation. Pre-clinical testing shows a drastic reduction in fear, anxiety and depression, as well as the restoration of cognitive function. This will establish the proof of concept for the approach and allow for expansion into Chronic PTSD. ReST has completed its Pre-IND meeting with the FDA and looks forward to entering the clinic in Q1 '26. Additional results demonstrating reduced neuroinflammation in neurodegenerative models paves the way for an extended development portfolio focusing on restoring the quality of lives of those affected by these debilitating diseases. Other research programs are focused on the neuropsychiatric aspects of Alzheimer's Diseases, Traumatic Brain Injury and Rett Syndrome.
Specialties
Where is ReST THERAPEUTICS located?
ReST THERAPEUTICS lists 3 office locations.
Compare companies similar to ReST THERAPEUTICS
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ReST THERAPEUTICS rest-therapeutics.com | Biotechnology | 10 | 2020 | New Haven, Connecticut |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about ReST THERAPEUTICS
What does ReST THERAPEUTICS do?
ReST Therapeutics is patient-centric, precision neuropsychiatric biotech developing transformative therapies for significant unmet medical needs. Founded in Paris, France in 2020 with an additional office in New Haven, Connecticut, (USA), our novel platform is engineered to address the pathophysiology of diseases rather than just the resulting symptoms. Our lead program, RST-101, will disrupt the existing PTSD treatment paradigm, focusing on the early treatment in the aftermath of a traumatic event and a patient-centric clinical strategy. RST-101 selectively targets the specific NMDA receptors sub-types, critical to memory consolidation. Pre-clinical testing shows a drastic reduction in fear, anxiety and depression, as well as the restoration of cognitive function. This will establish the proof of concept for the approach and allow for expansion into Chronic PTSD. ReST has completed its Pre-IND meeting with the FDA and looks forward to entering the clinic in Q1 '26. Additional results demonstrating reduced neuroinflammation in neurodegenerative models paves the way for an extended development portfolio focusing on restoring the quality of lives of those affected by these debilitating diseases. Other research programs are focused on the neuropsychiatric aspects of Alzheimer's Diseases, Traumatic Brain Injury and Rett Syndrome.
How many employees does ReST THERAPEUTICS have?
ReST THERAPEUTICS has around 10 employees on LinkedIn.
Where is ReST THERAPEUTICS headquartered?
ReST THERAPEUTICS is headquartered in New Haven, Connecticut.
Where does ReST THERAPEUTICS have offices?
ReST THERAPEUTICS lists 3 office locations, including New Haven, Connecticut, US; Paris, 75005, FR.
When was ReST THERAPEUTICS founded?
ReST THERAPEUTICS was founded in 2020.
Build a lead list from companies like ReST THERAPEUTICS
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.